日本表觀遺傳學市場報告（按產品、技術、應用和地區分類，2026-2034年）

Japan Epigenetics Market Report by Product, Technology, Application, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 118 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本表觀遺傳學市場規模達1.798億美元。展望未來， IMARC Group預計到2034年，該市場規模將達到4.9億美元，2026年至2034年期間的複合年成長率（CAGR）為11.78%。癌症、糖尿病和心血管疾病等慢性病病例的不斷增加，以及對用於治療這些疾病的表觀遺傳學研究和診斷需求的日益成長，是推動市場成長的主要因素。

本報告解答的關鍵問題：

日本表觀遺傳學市場目前表現如何？未來幾年又將如何發展？
新冠疫情對日本表觀遺傳學市場產生了哪些影響？
日本表觀遺傳學市場的產品組成是怎樣的？
日本表觀遺傳學市場按技術分類的組成是怎樣的？
日本表觀遺傳學市場按應用領域分類的組成是怎樣的？
日本表觀遺傳學市場價值鏈的各個階段有哪些？
日本表觀遺傳學的關鍵促進因素和挑戰是什麼？
日本表觀遺傳學市場的結構是怎麼樣的？主要參與者有哪些？
日本表觀遺傳學市場的競爭程度如何？

Japan epigenetics market size reached USD 179.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 490.0 Million by 2034, exhibiting a growth rate (CAGR) of 11.78% during 2026-2034. The escalating cases of chronic diseases such as cancer, diabetes, and cardiovascular diseases, coupled with the rising demand for epigenetic research and diagnostics to manage these conditions, are primarily driving the market.

Epigenetics refers to changes in gene expression that occur without alterations to the underlying DNA sequence. It involves modifications to the structure of DNA and its associated proteins, which can turn genes on or off, influencing an organism's traits and development. Epigenetic mechanisms include DNA methylation, where methyl groups are added to DNA, and histone modifications, which alter the packaging of DNA in the cell nucleus. These modifications can be influenced by environmental factors, lifestyle choices, and even experiences across generations. Epigenetics plays a crucial role in various biological processes, such as embryonic development, cellular differentiation, and the regulation of gene activity. It also has implications for health and disease, as epigenetic changes can contribute to the development of diseases like cancer, cardiovascular disease, and mental health disorders. Understanding epigenetics has the potential to shed light on the interplay between genetics and the environment, providing insights into gene regulations and their impact on health and well-being.

Japan Epigenetics Market Trends:

The epigenetics market in Japan has witnessed remarkable growth in recent years, primarily owing to its potential to revolutionize understanding of gene regulation and its implications in various fields. Firstly, advancements in technology, such as next-generation sequencing and high-throughput assays, have propelled the epigenetics market forward. These tools enable researchers to analyze DNA methylation, histone modifications, and non-coding RNA expression at an unprecedented scale and accuracy. Furthermore, the rising prevalence of complex diseases, including cancer, neurological disorders, and metabolic conditions, has driven the demand for epigenetic studies. Epigenetic alterations have been linked to the development and progression of these diseases, creating a pressing need for targeted therapies and diagnostic tools. Additionally, the growing awareness of the role of epigenetics in personalized medicine has sparked interest among pharmaceutical companies, further stimulating the market. Moreover, government and private investments in epigenetics research have surged, fostering innovation and collaboration among academic institutions and biotechnology firms. This financial support has accelerated the development of epigenetic drugs and diagnostic solutions. Lastly, the increasing adoption of epigenetic testing in clinical settings, coupled with a growing aging population, is expected to drive the epigenetics market in Japan during the forecast period.

apan Epigenetics Market Segmentation:

Product Insights:

Reagents
Kits
- Chip Sequencing Kit
- Whole Genomic Amplification Kit
- Bisulfite Conversion Kit
- RNA Sequencing Kit
- Others
Instruments
Enzymes
Services

Technology Insights:

DNA Methylation
Histone Methylation
Histone Acetylation
Large Non-Coding RNA
MicroRNA Modification
Chromatin Structures

Application Insights:

Oncology
- Solid Tumors
- Liquid Tumors
Non-Oncology
- Inflammatory Diseases
- Metabolic Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan epigenetics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan epigenetics market?
What is the breakup of the Japan epigenetics market on the basis of product?
What is the breakup of the Japan epigenetics market on the basis of technology?
What is the breakup of the Japan epigenetics market on the basis of application?
What are the various stages in the value chain of the Japan epigenetics market?
What are the key driving factors and challenges in the Japan epigenetics?
What is the structure of the Japan epigenetics market and who are the key players?
What is the degree of competition in the Japan epigenetics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Epigenetics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Epigenetics Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Epigenetics Market - Breakup by Product

6.1 Reagents
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Kits
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Chip Sequencing Kit
  - 6.2.3.2 Whole Genomic Amplification Kit
  - 6.2.3.3 Bisulfite Conversion Kit
  - 6.2.3.4 RNA Sequencing Kit
  - 6.2.3.5 Others
- 6.2.4 Market Forecast (2026-2034)
6.3 Instruments
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)
6.4 Enzymes
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2020-2025)
- 6.4.3 Market Forecast (2026-2034)
6.5 Services
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2020-2025)
- 6.5.3 Market Forecast (2026-2034)

7 Japan Epigenetics Market - Breakup by Technology

7.1 DNA Methylation
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Histone Methylation
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Histone Acetylation
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Large Non-Coding RNA
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)
7.5 MicroRNA Modification
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2020-2025)
- 7.5.3 Market Forecast (2026-2034)
7.6 Chromatin Structures
- 7.6.1 Overview
- 7.6.2 Historical and Current Market Trends (2020-2025)
- 7.6.3 Market Forecast (2026-2034)

8 Japan Epigenetics Market - Breakup by Application

8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Segmentation
  - 8.1.3.1 Solid Tumors
  - 8.1.3.2 Liquid Tumors
- 8.1.4 Market Forecast (2026-2034)
8.2 Non-Oncology
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Segmentation
  - 8.2.3.1 Inflammatory Diseases
  - 8.2.3.2 Metabolic Diseases
  - 8.2.3.3 Infectious Diseases
  - 8.2.3.4 Cardiovascular Diseases
  - 8.2.3.5 Others
- 8.2.4 Market Forecast (2026-2034)

9 Japan Epigenetics Market - Breakup by Region

9.1 Kanto Region
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Breakup by Product
- 9.1.4 Market Breakup by Technology
- 9.1.5 Market Breakup by Application
- 9.1.6 Key Players
- 9.1.7 Market Forecast (2026-2034)
9.2 Kansai/Kinki Region
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Breakup by Product
- 9.2.4 Market Breakup by Technology
- 9.2.5 Market Breakup by Application
- 9.2.6 Key Players
- 9.2.7 Market Forecast (2026-2034)
9.3 Central/ Chubu Region
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Breakup by Product
- 9.3.4 Market Breakup by Technology
- 9.3.5 Market Breakup by Application
- 9.3.6 Key Players
- 9.3.7 Market Forecast (2026-2034)
9.4 Kyushu-Okinawa Region
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Breakup by Product
- 9.4.4 Market Breakup by Technology
- 9.4.5 Market Breakup by Application
- 9.4.6 Key Players
- 9.4.7 Market Forecast (2026-2034)
9.5 Tohoku Region
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2020-2025)
- 9.5.3 Market Breakup by Product
- 9.5.4 Market Breakup by Technology
- 9.5.5 Market Breakup by Application
- 9.5.6 Key Players
- 9.5.7 Market Forecast (2026-2034)
9.6 Chugoku Region
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2020-2025)
- 9.6.3 Market Breakup by Product
- 9.6.4 Market Breakup by Technology
- 9.6.5 Market Breakup by Application
- 9.6.6 Key Players
- 9.6.7 Market Forecast (2026-2034)
9.7 Hokkaido Region
- 9.7.1 Overview
- 9.7.2 Historical and Current Market Trends (2020-2025)
- 9.7.3 Market Breakup by Product
- 9.7.4 Market Breakup by Technology
- 9.7.5 Market Breakup by Application
- 9.7.6 Key Players
- 9.7.7 Market Forecast (2026-2034)
9.8 Shikoku Region
- 9.8.1 Overview
- 9.8.2 Historical and Current Market Trends (2020-2025)
- 9.8.3 Market Breakup by Product
- 9.8.4 Market Breakup by Technology
- 9.8.5 Market Breakup by Application
- 9.8.6 Key Players
- 9.8.7 Market Forecast (2026-2034)

10 Japan Epigenetics Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Epigenetics Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis